262 related articles for article (PubMed ID: 15900093)
21. Economic impact of regression of left ventricular hypertrophy by antihypertensive drugs.
Eagle KA; Blank DJ; Aguiar E; Firth LM
J Hum Hypertens; 1993 Aug; 7(4):341-51. PubMed ID: 8105082
[TBL] [Abstract][Full Text] [Related]
22. [Nitric oxide--a potential modulator of left ventricular diastolic function in hemodialysis patients treated with erythropoietin].
Rasić S; Kulenović I; Zulić I; Huskić J; Avdagić N; Babić N; Uncanin S; Haracić A
Med Arh; 2004; 58(2):109-12. PubMed ID: 15202319
[TBL] [Abstract][Full Text] [Related]
23. Effects of angiotensin II receptor blockade-based therapy with losartan on left ventricular hypertrophy and geometry in previously treated hypertensive patients.
Cuspidi C; Meani S; Valerio C; Fusi V; Sala C; Maisaidi M; Zanchetti A
Blood Press; 2006; 15(2):107-15. PubMed ID: 16754274
[TBL] [Abstract][Full Text] [Related]
24. Regression of left ventricular hypertrophy by lisinopril after renal transplantation: role of ACE gene polymorphism.
Hernández D; Lacalzada J; Salido E; Linares J; Barragán A; Lorenzo V; Higueras L; Martín B; Rodríguez A; Laynez I; González-Posada JM; Torres A
Kidney Int; 2000 Aug; 58(2):889-97. PubMed ID: 10916115
[TBL] [Abstract][Full Text] [Related]
25. Effect of anemia correction on left ventricular hypertrophy in patients with modestly high hemoglobin level and chronic kidney disease .
Akaishi M; Hiroe M; Hada Y; Suzuki M; Tsubakihara Y; Akizawa T;
J Cardiol; 2013 Oct; 62(4):249-56. PubMed ID: 23787155
[TBL] [Abstract][Full Text] [Related]
26. Epoetin alfa's effect on left ventricular hypertrophy and subsequent mortality.
Jones M; Schenkel B; Just J
Int J Cardiol; 2005 Apr; 100(2):253-65. PubMed ID: 15823633
[TBL] [Abstract][Full Text] [Related]
27. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
[TBL] [Abstract][Full Text] [Related]
28. Echocardiographic changes following hemodialysis initiation in patients with advanced chronic kidney disease and symptomatic heart failure with reduced ejection fraction.
Ganda A; Weiner SD; Chudasama NL; Valeri AM; Jadoon A; Shimbo D; Radhakrishnan J
Clin Nephrol; 2012 May; 77(5):366-75. PubMed ID: 22551882
[TBL] [Abstract][Full Text] [Related]
29. Left ventricular geometry predicts cardiovascular outcomes associated with anemia correction in CKD.
Eckardt KU; Scherhag A; Macdougall IC; Tsakiris D; Clyne N; Locatelli F; Zaug MF; Burger HU; Drueke TB
J Am Soc Nephrol; 2009 Dec; 20(12):2651-60. PubMed ID: 19850955
[TBL] [Abstract][Full Text] [Related]
30. Angiotensin receptor blockers reduce left ventricular hypertrophy in dialysis patients: a meta-analysis.
Yang LY; Ge X; Wang YL; Ma KL; Liu H; Zhang XL; Liu BC
Am J Med Sci; 2013 Jan; 345(1):1-9. PubMed ID: 23018492
[TBL] [Abstract][Full Text] [Related]
31. [Erythropoietin-beta in the treatment of anemia in patients with chronic renal insufficiency].
Dimković N
Med Pregl; 2001; 54(5-6):235-40. PubMed ID: 11759218
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the effects of angiotensin receptor antagonist, angiotensin converting enzyme inhibitor, and their combination on regression of left ventricular hypertrophy of diabetes type 2 patients on recent onset hemodialysis therapy.
Suzuki H; Kanno Y; Kaneko K; Kaneko M; Kotaki S; Mimura T; Takane H
Ther Apher Dial; 2004 Aug; 8(4):320-7. PubMed ID: 15274684
[TBL] [Abstract][Full Text] [Related]
33. A pilot evaluation of the long-term effect of combined therapy with intravenous iron sucrose and erythropoietin in elderly patients with advanced chronic heart failure and cardio-renal anemia syndrome: influence on neurohormonal activation and clinical outcomes.
Comín-Colet J; Ruiz S; Cladellas M; Rizzo M; Torres A; Bruguera J
J Card Fail; 2009 Nov; 15(9):727-35. PubMed ID: 19879457
[TBL] [Abstract][Full Text] [Related]
34. Effects of treatment with epoetin beta on outcomes in patients with anaemia and chronic heart failure.
Silverberg DS; Wexler D; Blum M; Iaina A; Sheps D; Keren G; Scherhag A; Schwartz D
Kidney Blood Press Res; 2005; 28(1):41-7. PubMed ID: 15489560
[TBL] [Abstract][Full Text] [Related]
35. Left ventricular hypertrophy in new hemodialysis patients without symptomatic cardiac disease.
Foley RN; Curtis BM; Randell EW; Parfrey PS
Clin J Am Soc Nephrol; 2010 May; 5(5):805-13. PubMed ID: 20378644
[TBL] [Abstract][Full Text] [Related]
36. Cardiac mortality prevention in uremic patients. Therapeutic strategies with particular attention to complete correction of renal anemia.
Berweck S; Hennig L; Sternberg C; Dingerkus H; Ludat K; Hampl H
Clin Nephrol; 2000 Feb; 53(1 Suppl):S80-5. PubMed ID: 10746811
[TBL] [Abstract][Full Text] [Related]
37. Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial.
Devereux RB; Dahlöf B; Gerdts E; Boman K; Nieminen MS; Papademetriou V; Rokkedal J; Harris KE; Edelman JM; Wachtell K
Circulation; 2004 Sep; 110(11):1456-62. PubMed ID: 15326072
[TBL] [Abstract][Full Text] [Related]
38. Time-averaged hemoglobin values, not hemoglobin cycling, have an impact on outcomes in pediatric dialysis patients.
Bakkaloğlu SA; Kandur Y; Serdaroğlu E; Noyan A; Bayazıt AK; Taşdemir M; Özlü SG; Özçelik G; Dursun İ; Alparslan C; Akcaboy M; Atikel YÖ; Parmaksız G; Atmış B; Sever L
Pediatr Nephrol; 2018 Nov; 33(11):2143-2150. PubMed ID: 30105415
[TBL] [Abstract][Full Text] [Related]
39. Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey.
Cohen Solal A; Leurs I; Assyag P; Beauvais F; Clerson P; Contre C; Thebaut JF; Genoun M;
Arch Cardiovasc Dis; 2012; 105(6-7):355-65. PubMed ID: 22800720
[TBL] [Abstract][Full Text] [Related]
40. Serial echocardiographic changes in patients on hemodialysis: an evaluation of guideline implementation.
Covic A; Mardare NG; Ardeleanu S; Prisada O; Gusbeth-Tatomir P; Goldsmith DJ
J Nephrol; 2006; 19(6):783-93. PubMed ID: 17173253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
